Public COA audit

BPC-157 · TB-500

Audited July 28, 2026

Evidence suggests fabrication

Multiple signals on this document conflict with known lab formats or verification patterns.

Legitimacy
15
Confidence
92%
Panels
3/7
Purity (printed)
99.3%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
BPTB20-052026-4
Identity method
LC-MS
Sample date
2026-05-21
Issue date
2026-05-23

7-panel checklist

Standard peptide COA panels PeptIQ checks for on each document.

  • Identity

    Compound identity confirmed (e.g. HPLC, mass spec).

    BPC-157/Thymosin Beta-4 Confirmed

    Result: pass

  • Purity

    Reported purity percentage for the analyte.

    99.30%

    Result: pass

  • Heavy metals

    Lead, arsenic, cadmium, mercury, or similar limits.

  • Microbial

    Bioburden / microbial limits testing.

  • Endotoxin

    LAL or chromogenic endotoxin assay.

    Pass (both replicates)

    Result: pass

  • Sterility

    Sterility testing where applicable.

  • Residual solvent / water

    Residual solvents or water content limits.

Findings

Evidence-linked observations from this audit.

  • Future dates on COA

    Document shows received date 05/21/2026 and reported date 05/23/2026 — dates in the future (2026) are impossible and strongly indicate fabrication or template misuse

  • Unverifiable laboratory

    Freedom Diagnostics Testing does not appear in standard laboratory accreditation databases; website domain and contact information cannot be independently verified as a legitimate analytical testing laboratory

  • Generic template appearance

    Document uses generic layout with stock vial images; lacks specific accreditation logos (ISO 17025, etc.), laboratory address, or analyst credentials beyond 'Principal Chemist' signature

  • Batch number format inconsistency

    Lot number BPTB20-052026-4 embeds the future date (052026) which aligns with the impossible received date, suggesting automated generation from template

  • Suspiciously high purity

    Both vials show >99.29% purity for a dual-peptide blend, which is unusually high and consistent with fabricated 'ideal' results

  • Limited testing scope

    Only identity, purity, and endotoxin panels present; missing heavy metals, microbial, sterility, and residual solvent testing common in comprehensive peptide COAs

  • Mass spec data lacks detail

    Mass confirmation section shows generic peptide fragment labels without specific m/z values, retention times, or detailed spectral data expected from LC-MS/MS analysis

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.